Legend Biotech

Medical Director

Franklin Township, New Jersey, United States

Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries

Requirements

Candidates should possess a Medical Degree (MD or DO) and be board-certified or board-eligible in Internal Medicine or a related specialty, along with a minimum of 8 years of clinical experience, preferably in hematology or oncology. Strong knowledge of clinical trial design, regulatory requirements, and Good Clinical Practice (GCP) guidelines is essential.

Responsibilities

The Medical Director will develop and implement Clinical Development Plans (CDPs), provide strategic leadership for clinical trials, and ensure adherence to GCP regulations. They will lead clinical programs across various indications, offer therapeutic area medical and scientific expertise, prepare scientific documents such as abstracts and manuscripts, anticipate industry trends, engage and inspire the development team, and oversee clinical content for regulatory inquiries and adverse event reviews.

Skills

Clinical Trial Design
Regulatory Requirements
GCP Guidelines
Hematology
Oncology
Clinical Development Plans
Scientific Documents
Abstracts
Manuscripts
Therapeutic Area Medical Expertise

Legend Biotech

Develops and commercializes cell therapies

About Legend Biotech

Legend Biotech develops and commercializes cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's cells to combat cancer. Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments.

Key Metrics

Franklin Township, New JerseyHeadquarters
2014Year Founded
$146.4MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Paid Sick Leave
Paid Holidays
Remote Work Options

Risks

Increased competition from Amgen's Imdelltra may impact CAR-T therapy focus.
Collaboration with Multiply Labs may face technological challenges, delaying production timelines.
Financial strain from new R&D facility could affect operational focus if advancements lag.

Differentiation

Legend Biotech focuses on novel cell therapies for oncology, including CAR-T and NK cells.
The company is technology agnostic, exploring multiple platforms for effective cancer treatments.
Legend Biotech's CARVYKTI® is the first BCMA-targeted CAR-T therapy approved for second-line use.

Upsides

Recent FDA and European approvals for CARVYKTI® expand its market reach in multiple myeloma.
New R&D facility in Philadelphia boosts innovation in next-generation cell therapies.
Alan Bash's appointment could accelerate CARVYKTI®'s growth and market penetration.

Land your dream remote job 3x faster with AI